Ms. Carroll has nearly two decades of experience working with customers in government and commercial healthcare organizations to implement clinical trials management and observation outcomes solutions.

As Digital Infuzion’s Vice President of N of 1 Professional Services, Ms. Carroll is a member of the executive committee that helps define and implement the strategic direction of the N of 1 Health Research Platform, drives innovation within the platform to improve patient engagement in observational studies, and manages the continued growth of the N of 1 Health Research Platform by delivering exceptional customer service to all of our customers.

The N of 1 Health Research Platform is a SaaS solution used by pharmaceutical companies, biotech companies, patient advocacy/non-profit groups, and academic organizations to implement Patient Registries and Observational Studies in the rare disease domain. Ms. Carroll utilizes her extensive knowledge of U.S. and European regulatory guidelines for clinical systems, data interchange standards such as CDISC ODM and HL7, and best practices for design of electronic case report forms, to help design and implement registry solutions that accelerate the research and help to improve the lives of the rare disease patient community.